Have a personal or library account? Click to login
DEL phenotype Cover

References

  1. Okubo Y, Yamaguchi H, Tomita T, Nagao N. A D variant, Del? Transfusion 1984;24:542.10.1046/j.1537-2995.1984.24685066827.x6438843
  2. Okubo Y, Seno T, Yamano H, et al. Partial D antigens disclosed by a monoclonal anti-D in Japanese blood donors. Transfusion 1991;31:782.10.1046/j.1537-2995.1991.31892023512.x1926326
  3. Fukumori Y, Hori Y, Ohnoki, et al. Further analysis of Del (D-elute) using polymerase chain reaction (PCR) with RHD gene-specific primers. Transfus Med 1997;7:227–31.10.1046/j.1365-3148.1997.d01-31.x9316224
  4. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.10.1186/1471-2156-2-103726711495631
  5. Shao CP, Maas JH, Su YQ, et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156–61.10.1046/j.1423-0410.2002.00192.x12201845
  6. Shao CP. Transfusion of RhD-positive blood in “Asia type” DEL recipients. N Engl J Med 2010;362:472–3.10.1056/NEJMc090955220130261
  7. Singleton BK, Green CA, Kimura K, et al. Two new RHD mutations associated with the Del phenotype (abstract). Transfus Clin Biol 2001;8(Suppl 1):9s.
  8. Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommendations for the description of sequence variants: 2016 Update. Human Mutat 2016;37:564–9.10.1002/humu.2298126931183
  9. Chen J-C, Lin T-M, Chen YI, et al. RHD 1227A is an important genetic marker for RhDel individuals. Am J Clin Pathol 2004;122:193–8.10.1309/3XMF2NV5707TJE7X
  10. Shao CP, Xu H, Xu Q, et al. Antenatal Rh prophylaxis is unnecessary for “Asia type” DEL women. Transfus Clin Biol 2010;17:260–4.10.1016/j.tracli.2010.07.00320961786
  11. Chang JG, Wang JC, Yang TY, et al. Human RhD el is caused by a deletion of 1013 bp between introns 8 and 9 including exon 9 of RHD gene (letter). Blood 1998;92:2602–4.10.1182/blood.V92.7.2602
  12. Luettringhaus TA, Cho D, Ryang DW, Flegel WA. An easy RHD genotyping strategy for D– East Asian persons applied to Korean blood donors. Transfusion 2006;46:2128–37.10.1111/j.1537-2995.2006.01042.x17176325
  13. Wagner FF. RHD PCR of D-negative blood donors. Transfus Med Hemother 2013;40:172–81.10.1159/000351604372502223922542
  14. Wagner FF, Flegel WA. The rhesus site. Transfus Med Hemother 2014;41357–63. (The human RhesusBase, version 2.0. http://www.rhesusbase.info/, update 2017-02-19.)
  15. Shao C, Wang B, Ye S, et al. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness. J Zhejiang Univ Sci B 2012;13:913–8.10.1631/jzus.B1100348349403023125084
  16. Yang HS, Lee MY, Park TS, et al. Primary anti-D alloimmunization induced by “Asian type” RHD (C.1227G>A) DEL red cell transfusion. Ann Lab Med 2015;35:554–6.10.3343/alm.2015.35.5.554451051426206698
  17. Li Q, Hou L, Ye LY, et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 2009;97:139–46.10.1111/j.1423-0410.2009.01181.x19490579
  18. Ji YL, Van der Schoot CE. Red blood cell genotyping in China. ISBT Sci Ser 2016;11:55–68.10.1111/voxs.12272
  19. Gu J, Wang X, Shao C, et al. Molecular basis of DEL phenotype in the Chinese population. BMC Med Gen 2014;15:54.10.1186/1471-2350-15-54402411624884404
  20. Yang YE, Wang YH, Chen JC, et al. Prevalence of RHD1227A and hybrid rhesus in the general Chinese population. Translat Res 2007;149:31–6.10.1016/j.trsl.2006.03.00617196520
  21. Okuda H, Kawano M, Iwamoto S, et al. The RHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest 1997;100:373–9.10.1172/JCI1195435082009218514
  22. Kim YJ, Kim YS, Kim C, et al. Molecular characterization of D– Korean persons; development of a diagnostic strategy. Transfusion 2005;45:345–52.10.1111/j.1537-2995.2005.04311.x15752151
  23. Kim K, Kim K, Wook K, et al. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med 2009;29:361–5.10.3343/kjlm.2009.29.4.36119726900
  24. Flegel WA, Zabern IV, Wagner FF. Six years’ experience performing RHD genotyping to confirm D– red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009;49:465–71.10.1111/j.1537-2995.2008.01975.x19243542
  25. Daniels G. Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002.10.1002/9780470987018
  26. Wagner FF, Ladewig B, Angert KS, Heymann GA, Eicher NI, Flegel WA. The DAU allele cluster of the RHD gene. Blood 2002;100:306–11.10.1182/blood-2002-01-032012070041
  27. Mak KH, Yan KH, Cheng SS, Yuen MY. Rh phenotypes of Chinese blood donors in Hong Kong, with special reference to weak D antigens. Transfusion 1993;33:348–51.10.1046/j.1537-2995.1993.33493242645.x8480357
  28. Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion 2005;45:520–6.10.1111/j.0041-1132.2005.04256.x15819672
  29. von Zabern I, Flegel WA. IVS5-38del4 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion 2007;47:1552–5.10.1111/j.1537-2995.2007.01353.x17655603
  30. Yasuda H, Ohto H, Sakuma S, et al. Secondary anti-D immunization by Del red blood cells. Transfusion 2005;45:1581–4.10.1111/j.1537-2995.2005.00579.x16181208
  31. Körmöczi GF, Gassner C, Shao CP, et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005;45:1561–7.10.1111/j.1537-2995.2005.00584.x16181205
  32. Flegel WA. Response to: Are weak D RBCs really immunogenic? (letter). Transfusion 2006;46:1063–4.10.1111/j.1537-2995.2006.00850.x
  33. Wang QP, Dong GT, Wang XD, et al. An investigation of secondary anti-D immunization among phenotypically RhD-negative individuals in the Chinese population. Blood Transfus 2014;12:238–43.
  34. Wang M, Wang BL, Xu W, et al. Anti-D alloimmunization in pregnant women with DEL phenotype in China. Transfus Med 2015;25;163–9.10.1111/tme.1221126033335
  35. Xu W, Zhu M, Wang BL, et al. Prospective evaluation of a transfusion policy of RhD-positive red blood cells into DEL patients in China. Transfus Med Hemother 2015;42:15–21.10.1159/000370217440493225960711
  36. Gardener GJ, Legler TJ, Hyett JA, et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL pheno-type. Transfusion 2012;52:2016–9.10.1111/j.1537-2995.2011.03538.x22313164
  37. Wang YH, Chen JC, Lin KT, et al. Detection of RhD(el) in RhD-negative persons in clinical laboratory. J Lab Clin Med 2005;146:321–5.10.1016/j.lab.2005.07.00716310514
  38. Seo MH, Won EJ, Hong YJ, et al. An effective diagnostic strategy for accurate detection of RhD variants including Asian DEL type in apparently RhD-negative blood donors in Korea. Vox Sang 2016;111:425–30.10.1111/vox.1245027864976
  39. Ogasawara K, Suzuki Y, Sasaki K, et al. Molecular basis for D– Japanese: identification of novel DEL and D-alleles. Vox Sang 2015;109:359–65.10.1111/vox.1229025953588
  40. Gu J, Wang X, Shao C, et al. Molecular basis of DEL phenotype in the Chinese population. BMC Med Genet 2014;15:54.10.1186/1471-2350-15-54402411624884404
  41. Li Q, Ye LY, Guo ZH, Zhang YX, et al. Molecular basis of D variants between Uigur and Han blood donors in Xinjiang. Transfus Med 2008;18:199–203.10.1111/j.1365-3148.2008.00857.x18598284
  42. Wu JJ, Hong XZ, Xu XG, et al. RHD 1227A allele frequency among Rh negative population and random population. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006;14:1234–7.
  43. Hoeffel EM, Rastogi S, Kim MO, Shahid H. The Asian population: 2010. Suitland, MD: United States Census Bureau, 2010.
  44. Wu X, Wu D, Wang M, et al. Analysis of frequency of a RHD1227A allele in Chinese Hans (abstract). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2014;31:793–6.
  45. Li JH, Zhang CY, Sun LH, Liu J. Molecular mechanisms of RhDel phenotype in blood donation population of Chinese Harbin area (abstract). Zhongguo Shi Yan Xue Ye Xue Za Zhi (Chinese) 2012;20:1478–81.
  46. Chen Q, Li M, Li M, et al. Molecular basis of weak D and DEL in Han population in Anhui Province, China (abstract). Chin Med J (Engl) 2012;125:3251–5.
  47. Sun CF, Liu JP, Chen DP, et al. Use of real time PCR for rapid detection of Del phenotype in Taiwan. Ann Clin Lab Sci 2008;38:258–63.
  48. Yazer MH, Vassallo R, Delaney M, et al. Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States. Transfusion 2017;57:1644–55.10.1111/trf.1410828370164
  49. Yazer MH, Delaney M, Germain M, et al. Trends in US minority red blood cell unit donations. Transfusion 2017;57:1226–3410.1111/trf.1403928205236
  50. Flegel WA, Castilho SL, Keller MA, et al. Molecular immunohematology round table discussions at the AABB Annual Meeting, Philadelphia 2014. Blood Transfus 2016; 14:425–33.
  51. Garratty G. Do we need to be more concerned with weak D antigens? Transfusion 2005;45:1547–51.10.1111/j.1537-2995.2005.00625.x16181202
  52. Denomme GA, Flegel WA. Applying molecular immuno-hematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008;48:2461–75.10.1111/j.1537-2995.2008.01855.x19054376
DOI: https://doi.org/10.21307/immunohematology-2019-019 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 125 - 132
Published on: Oct 9, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 D.H. Kwon, S.G. Sandler, W.A. Flegel, published by American National Red Cross
This work is licensed under the Creative Commons License.